Fates and osteogenic differentiation potential of human mesenchymal stem cells in immunocompromised mice. by Xia, Z, Locklin, R, Triffitt, J

Modulation of osteogenic differentiation in human skeletal cells in Vitro by 5-azacytidine. by Locklin, R, Oreffo, R, Triffitt, J

Effects of TGFbeta and bFGF on the differentiation of human bone marrow stromal fibroblasts. by Locklin, R, Oreffo, R, Triffitt, J

Agonists of TRAIL death receptors induce myeloma cell apoptosis that is not prevented by cells of the bone marrow microenvironment. by Locklin, R, Croucher, P, Russell, R, Edwards, C

Lactoferrin protects osteoblasts and osteocytes from apoptosis by Locklin, R, Hulley, P, Naot, D, Cornish, J

Osteoblasts protect multiple myeloma cells from T-cell-induced apoptosis by Locklin, R, Russell, R, Croucher, P, Edwards, C

Cells of the bone marrow microenvironment protect myeloma cells from apoptosis induced by TRAIL but not by agonists of TRAIL death receptors. by Locklin, R, Croucher, P, Russell, R, Shipman, C

Sulforaphane - A new therapy for mutliple myeloma? by Locklin, R, Hulley, P, Russell, R, Edwards, C

In vitro effects of growth factors and dexamethasone on rat marrow stromal cells. by Locklin, R, Williamson, M, Beresford, J, Triffitt, J, Owen, M

Differential sensitivity of normal osteoblast-like cells and osteosarcoma cells to TRAIL and an agonist antibody to TRAIL receptor-2 by Locklin, R, Federici, E, Croucher, P, Russell, R, Shipman, C

Innate immune response to human bone marrow fibroblastic cell implantation in CB17 scid/beige mice. by Xia, Z, Taylor, P, Locklin, R, Gordon, S, Cui, Z, Triffitt, J

Selective targeting of death receptor 5 circumvents resistance of MG-63 osteosarcoma cells to TRAIL-induced apoptosis. by Locklin, R, Federici, E, Espina, B, Hulley, P, Russell, R, Edwards, C

Keratin 18 is over-expressed in osteoblasts derived from Pagetic lesions but is not involved in the formation of disrupted matrix by Naot, D, Matthews, BG, Locklin, R, Xia, Z, Hulley, P, Cornish, J

Efficient characterisation of human cell-bioceramic interactions in vitro and in vivo by using enhanced GFP-labelled mesenchymal stem cells. by Xia, Z, Ye, H, Locklin, R, Ferguson, D, Cui, Z, Triffitt, J

Selective targeting of DR5 circumvents resistance of MG-63 osteosarcoma to trail-induced apoptosis by Locklin, R, Federici, E, Espina, B, Hulley, P, Russell, R, Shipman, C

LIGHT (TNFSF14), a novel mediator of bone resorption, is elevated in rheumatoid arthritis. by Edwards, J, Sun, S, Locklin, R, Shipman, C, Adamopoulos, I, Athanasou, N, Sabokbar, A

Potential bone mineral binding differences among bisphosphonates can be demonstrated by the use of hydroxyapatite column chromatography. by Lawson, M, Triffitt, J, Ebetino, F, Barnett, B, Phipps, R, Locklin, R, Russell, R

Stimulation of osteoclast formation by inflammatory synovial fluid by Adamopoulos, I, Danks, L, Itonaga, I, Locklin, R, Sabokbar, A, Ferguson, D, Athanasou, N

Stimulation of osteoclast formation by inflammatory synovial fluid. by Adamopoulos, I, Danks, L, Itonaga, I, Locklin, R, Sabokbar, A, Ferguson, D, Athanasou, N

Differential allelic expression of protein tyrosine phosphatase NonReceptor 22 in rheumatoid arthritis patients by Harrison, P, Southam, L, Pointon, J, Chapman, K, Locklin, R, Sabokbar, A, Wordsworth, B